38:@0.048407:0.056159:0.063199:0.056159:0.063199:0.047246:0.048407:0.047246:0.007059:0.007732
Performance analysis:@0.739373:0.058552:0.904415:0.058552:0.904415:0.047968:0.739373:0.047968:0.010092:0.008830:0.006355:0.006419:0.009996:0.006563:0.014962:0.008591:0.010060:0.007665:0.008974:0.005637:0.008990:0.010092:0.008990:0.004710:0.009070:0.007313:0.004710:0.007026
Figure 8::@0.048828:0.102566:0.115068:0.102566:0.115068:0.091424:0.048828:0.091424:0.008404:0.004774:0.009850:0.009833:0.006387:0.008740:0.005211:0.008488:0.004555
16,484 clinical and non-clinical claims were settled  in 2021/22 compared with  15,712  in 2020/21 :@0.049248:0.119076:0.790806:0.119076:0.790806:0.107934:0.049248:0.107934:0.009244:0.009060:0.003647:0.009312:0.009060:0.009261:0.005631:0.008068:0.004068:0.004252:0.009749:0.004068:0.008118:0.008824:0.004068:0.006858:0.008555:0.009513:0.009900:0.006740:0.009749:0.010085:0.009833:0.006891:0.007765:0.004252:0.004068:0.009883:0.004068:0.008034:0.008824:0.004068:0.006522:0.007765:0.004252:0.008555:0.004068:0.014858:0.007127:0.004975:0.013278:0.009497:0.006387:0.009581:0.006051:0.007396:0.008791:0.005916:0.005698:0.004068:0.009144:0.010169:0.004605:0.002706:0.003698:0.008824:0.006387:0.008824:0.008824:0.008740:0.008740:0.006303:0.008740:0.008740:0.006471:0.007765:0.010303:0.014791:0.009883:0.008858:0.005849:0.009026:0.010169:0.005631:0.013447:0.004454:0.006303:0.010505:0.004605:0.002622:0.009060:0.009060:0.003479:0.009060:0.009060:0.009060:0.004605:0.002757:0.003614:0.008488:0.006387:0.008404:0.008488:0.008404:0.008488:0.006135:0.008488:0.008488:0.004605
with an  increasing percentage settled without proceedings1:@0.047567:0.135644:0.520531:0.135644:0.520531:0.124503:0.047567:0.124503:0.013447:0.004454:0.006303:0.010505:0.006471:0.008555:0.009177:0.004605:0.002706:0.004068:0.009883:0.007765:0.006101:0.008791:0.008858:0.007312:0.004068:0.009715:0.010085:0.006807:0.010337:0.009076:0.006135:0.008068:0.009244:0.009917:0.005967:0.008824:0.010337:0.009244:0.006051:0.007312:0.008791:0.006001:0.005883:0.004068:0.009043:0.010169:0.005631:0.013531:0.004454:0.006303:0.010505:0.010925:0.010505:0.006303:0.006051:0.010421:0.006051:0.010253:0.008152:0.009160:0.009244:0.010337:0.004068:0.010051:0.010337:0.007480:0.009060
10,000:@0.068576:0.174759:0.109251:0.174759:0.109251:0.165846:0.068576:0.165846:0.007315:0.007396:0.003442:0.007396:0.007396:0.007732
8,000:@0.075048:0.220905:0.108745:0.220905:0.108745:0.211992:0.075048:0.211992:0.007476:0.003644:0.007369:0.007476:0.007732
6.000:@0.075048:0.267110:0.108745:0.267110:0.108745:0.258197:0.075048:0.258197:0.007476:0.003644:0.007369:0.007476:0.007732
4.000:@0.074628:0.313315:0.108997:0.313315:0.108997:0.304402:0.074628:0.304402:0.007732:0.003644:0.007732:0.007530:0.007732
2.000:@0.075469:0.359758:0.109165:0.359758:0.109165:0.350845:0.075469:0.350845:0.007476:0.003644:0.007369:0.007476:0.007732
fO:@0.094798:0.405838:0.109181:0.405838:0.109181:0.397482:0.094798:0.397482:0.004828:0.009555
No proceedings:@0.152870:0.422942:0.250706:0.422942:0.250706:0.414586:0.152870:0.414586:0.009581:0.007400:0.005206:0.008156:0.005295:0.007980:0.006303:0.007223:0.007148:0.008156:0.003580:0.008106:0.008156:0.005547
 :@0.250944:0.422942:0.254398:0.422942:0.254398:0.414586:0.250944:0.414586:0.003454
2021/22:@0.177072:0.434977:0.225542:0.434977:0.225542:0.425909:0.177072:0.425909:0.007564:0.007475:0.007475:0.007475:0.004702:0.007475:0.006303
No proceedings:@0.273872:0.422942:0.371695:0.422942:0.371695:0.414586:0.273872:0.414586:0.009581:0.007400:0.004790:0.008156:0.005295:0.008068:0.006391:0.007223:0.007148:0.008232:0.003580:0.008181:0.008232:0.005547
 :@0.371947:0.422942:0.375401:0.422942:0.375401:0.414586:0.371947:0.414586:0.003454
2020/21:@0.298077:0.434345:0.346006:0.434345:0.346006:0.425989:0.298077:0.425989:0.007059:0.007249:0.006959:0.006971:0.005585:0.006858:0.007249
Proceedings:@0.403815:0.422942:0.478960:0.422942:0.478960:0.414586:0.403815:0.414586:0.007980:0.005017:0.008181:0.006303:0.007059:0.007059:0.008156:0.003580:0.008106:0.008156:0.005547
2020/21:@0.416321:0.434220:0.464584:0.434220:0.464584:0.426421:0.416321:0.426421:0.007224:0.007142:0.007224:0.007142:0.005542:0.007224:0.006765
Proceedings:@0.524834:0.422942:0.599979:0.422942:0.599979:0.414586:0.524834:0.414586:0.007980:0.005017:0.008181:0.006303:0.007059:0.007059:0.008156:0.003580:0.008106:0.008156:0.005547
2021/22:@0.537356:0.434220:0.586313:0.434220:0.586313:0.426421:0.537356:0.426421:0.007306:0.007224:0.007401:0.007224:0.005636:0.007401:0.006765
Trial:@0.669199:0.422942:0.695054:0.422942:0.695054:0.414586:0.669199:0.414586:0.007387:0.004803:0.003580:0.006505:0.003580
2020/21:@0.657954:0.434345:0.706135:0.434345:0.706135:0.425989:0.657954:0.425989:0.007059:0.007249:0.006959:0.007059:0.005585:0.007022:0.007249
Trial:@0.788638:0.422942:0.814493:0.422942:0.814493:0.414586:0.788638:0.414586:0.007387:0.004803:0.003580:0.006505:0.003580
2021/22:@0.776956:0.434345:0.826032:0.434345:0.826032:0.425989:0.776956:0.425989:0.007249:0.007249:0.007249:0.007249:0.005585:0.007249:0.007249
|   Damages:@0.153290:0.457513:0.235005:0.457513:0.235005:0.448600:0.153290:0.448600:0.004384:0.010569:0.003711:0.005957:0.009910:0.006898:0.012102:0.007059:0.008149:0.007059:0.005916
| |   No damages:@0.302967:0.457513:0.403089:0.457513:0.403089:0.448600:0.302967:0.448600:0.004384:0.003012:0.004384:0.003093:0.003711:0.003604:0.009749:0.007557:0.004451:0.008323:0.007234:0.012317:0.007006:0.008323:0.007059:0.005916
A total of  12,623 claims were settled without proceedings in 2021/22 (compared with  11,738 in 2020/21). :@0.047567:0.512050:0.815950:0.512050:0.815950:0.501466:0.047567:0.501466:0.011353:0.004790:0.005205:0.009357:0.005190:0.008128:0.003641:0.006467:0.009357:0.004758:0.004375:0.002858:0.008910:0.008990:0.003465:0.008894:0.008910:0.008830:0.006467:0.007377:0.003625:0.007904:0.003864:0.013365:0.006770:0.004663:0.011768:0.008655:0.005557:0.008734:0.006052:0.006563:0.008064:0.005205:0.005413:0.003577:0.008064:0.009070:0.005301:0.012024:0.004040:0.005716:0.009405:0.009836:0.009405:0.005637:0.006052:0.009165:0.005557:0.009070:0.007377:0.008000:0.008351:0.009038:0.003864:0.008830:0.009405:0.006483:0.006052:0.003273:0.007569:0.006467:0.008607:0.008958:0.008830:0.008910:0.006227:0.008990:0.008830:0.006052:0.004615:0.007377:0.009006:0.013525:0.009389:0.007760:0.005557:0.008144:0.009405:0.005477:0.011768:0.003864:0.005716:0.009325:0.004375:0.003689:0.008990:0.008990:0.003465:0.009054:0.008990:0.008910:0.006467:0.003273:0.007569:0.006467:0.008607:0.008958:0.008607:0.008958:0.006227:0.008814:0.008830:0.004822:0.003465:0.004375
This reflects an ongoing  improvement in our litigation  rate over the medium-term, settling  more claims before :@0.047987:0.527491:0.837400:0.527491:0.837400:0.516907:0.047987:0.516907:0.008367:0.008686:0.003864:0.006563:0.006052:0.005381:0.008160:0.004998:0.003864:0.008032:0.007377:0.005142:0.006770:0.005493:0.007649:0.008495:0.006467:0.009165:0.009038:0.009038:0.009070:0.003864:0.008734:0.009165:0.004375:0.002523:0.003864:0.013748:0.009197:0.005557:0.009357:0.007441:0.008351:0.013493:0.008351:0.009038:0.005142:0.006052:0.003273:0.007649:0.006467:0.009165:0.008830:0.005381:0.005637:0.003864:0.003609:0.005205:0.003864:0.009086:0.007904:0.005205:0.003864:0.009086:0.008830:0.004375:0.002523:0.005557:0.007808:0.005205:0.008064:0.005637:0.009070:0.007473:0.008351:0.005349:0.004870:0.005413:0.009038:0.008080:0.006052:0.013748:0.008351:0.009165:0.003864:0.009038:0.013573:0.006387:0.005413:0.008351:0.005557:0.013748:0.003465:0.006659:0.006467:0.008064:0.005205:0.005413:0.003657:0.003864:0.008655:0.009070:0.004375:0.002523:0.013285:0.008910:0.005301:0.007984:0.005637:0.007377:0.003864:0.007840:0.003864:0.013525:0.006770:0.006004:0.008990:0.008064:0.004998:0.008862:0.005381:0.008064:0.004375
formal court proceedings are required,  based on our deployment of dispute resolution techniques, such as :@0.047987:0.542933:0.811197:0.542933:0.811197:0.532348:0.047987:0.532348:0.004998:0.009357:0.005557:0.013748:0.008128:0.003864:0.006036:0.007377:0.009357:0.009038:0.005557:0.005413:0.005956:0.009165:0.005557:0.009070:0.007377:0.008000:0.008351:0.009038:0.003864:0.008830:0.009405:0.006483:0.005637:0.007808:0.005301:0.007904:0.006052:0.005381:0.008160:0.009405:0.008750:0.003864:0.005381:0.008160:0.009405:0.003194:0.004375:0.002523:0.008990:0.007649:0.006467:0.007904:0.008910:0.006467:0.008575:0.008399:0.006387:0.009070:0.009038:0.005333:0.005205:0.009405:0.008160:0.009389:0.003864:0.009357:0.007728:0.013748:0.008351:0.009038:0.005413:0.005557:0.009357:0.004758:0.005205:0.009405:0.003625:0.006770:0.009118:0.009038:0.005158:0.008160:0.006387:0.005301:0.007984:0.006770:0.008942:0.003864:0.008734:0.005205:0.003864:0.009086:0.008830:0.005716:0.005413:0.008623:0.007377:0.009038:0.009309:0.003864:0.009405:0.009261:0.008351:0.006946:0.003465:0.006451:0.006563:0.008655:0.007138:0.008734:0.006052:0.007473:0.006211:0.004375
mediation and  more collaboration with claimant lawyers.  This has been achieved without compromising :@0.048828:0.558551:0.794856:0.558551:0.794856:0.547967:0.048828:0.547967:0.013445:0.008160:0.009405:0.003625:0.008128:0.005158:0.003864:0.009086:0.009038:0.006339:0.007808:0.008575:0.008990:0.004375:0.002523:0.013285:0.008910:0.005301:0.007984:0.005716:0.007377:0.009102:0.003864:0.003864:0.007904:0.009389:0.009181:0.005557:0.008128:0.005142:0.003864:0.009165:0.009038:0.005589:0.011928:0.004040:0.005716:0.009405:0.006052:0.007377:0.003864:0.008128:0.003864:0.014084:0.008128:0.009038:0.005605:0.005637:0.003864:0.008128:0.011545:0.007728:0.008351:0.005557:0.006770:0.003465:0.004375:0.002411:0.008367:0.008607:0.003864:0.006563:0.006052:0.008734:0.007728:0.006563:0.005637:0.008990:0.007904:0.007904:0.008655:0.006467:0.008128:0.006994:0.009038:0.003657:0.008160:0.007473:0.008351:0.009134:0.005637:0.012024:0.004040:0.005716:0.009405:0.009836:0.009405:0.005637:0.005301:0.007377:0.009006:0.013525:0.009165:0.005557:0.009150:0.013445:0.003864:0.006563:0.003864:0.008830:0.009405:0.004375
the rigour of our investigation of eligibility for compensation.  Indeed, for clinical claims, the percentage :@0.047987:0.573933:0.789864:0.573933:0.789864:0.563348:0.047987:0.563348:0.005413:0.009038:0.008160:0.006467:0.005301:0.003864:0.009086:0.009070:0.008830:0.005381:0.005637:0.009357:0.004758:0.005301:0.009357:0.009038:0.005381:0.005637:0.003864:0.008734:0.007473:0.008160:0.006770:0.005158:0.003864:0.009165:0.007904:0.005413:0.003864:0.009038:0.009038:0.006339:0.009357:0.004758:0.005637:0.007984:0.003864:0.003864:0.008990:0.003864:0.009086:0.003864:0.003864:0.003625:0.005205:0.007728:0.004631:0.004998:0.009549:0.005557:0.005796:0.007377:0.009357:0.013748:0.009389:0.008351:0.009038:0.006770:0.008128:0.005413:0.003864:0.009357:0.009038:0.003465:0.004375:0.002842:0.004247:0.008702:0.009405:0.007984:0.008351:0.009134:0.003465:0.005940:0.004998:0.009549:0.005557:0.005365:0.007058:0.003864:0.003864:0.008575:0.003864:0.007058:0.007904:0.003864:0.006387:0.007377:0.003864:0.007840:0.003864:0.013748:0.006770:0.003465:0.005940:0.005413:0.009038:0.008080:0.006052:0.009389:0.008000:0.005557:0.007377:0.008080:0.009038:0.005413:0.007904:0.009405:0.008160:0.004375
of claims that have resolved without damages being  paid  has increased from 43.7%  (2020/21) to 48.5% :@0.048407:0.589315:0.801046:0.589315:0.801046:0.578730:0.048407:0.578730:0.009357:0.004758:0.005637:0.007377:0.003625:0.007904:0.003864:0.013365:0.006770:0.005078:0.005413:0.009373:0.008319:0.005413:0.005764:0.008830:0.007904:0.007473:0.008064:0.006052:0.005205:0.007904:0.006467:0.008910:0.003864:0.007138:0.007984:0.008990:0.005716:0.012024:0.004040:0.005716:0.009405:0.009836:0.009405:0.005637:0.005205:0.009405:0.008128:0.013557:0.008128:0.009405:0.008351:0.006770:0.006084:0.008910:0.007904:0.003609:0.008575:0.008910:0.004375:0.002427:0.008830:0.007473:0.003609:0.008734:0.004375:0.002523:0.008655:0.007728:0.006563:0.006052:0.003864:0.008734:0.007138:0.005381:0.008160:0.007808:0.006770:0.007936:0.009165:0.005637:0.004998:0.005557:0.009022:0.013525:0.006052:0.009660:0.009756:0.003864:0.009660:0.014626:0.004375:0.002523:0.004822:0.009038:0.008607:0.008958:0.008607:0.006515:0.008607:0.008958:0.004822:0.005269:0.005413:0.009134:0.005205:0.009581:0.009660:0.003864:0.009581:0.014547:0.004375
(2021/22). This includes claims managed  under our CNSGP and  ELSGP schemes, which have different :@0.048407:0.604697:0.776919:0.604697:0.776919:0.594112:0.048407:0.594112:0.004822:0.009038:0.008830:0.008830:0.008607:0.006515:0.008607:0.008958:0.004822:0.003465:0.006595:0.008367:0.008607:0.003864:0.006563:0.006052:0.003864:0.008734:0.007138:0.003864:0.008830:0.009405:0.007984:0.006770:0.005493:0.007377:0.003864:0.007840:0.003864:0.013525:0.006770:0.006004:0.013525:0.007904:0.009038:0.007856:0.009165:0.008351:0.009134:0.004375:0.002427:0.009038:0.008782:0.009405:0.008080:0.005557:0.005541:0.009070:0.009038:0.005333:0.005205:0.010092:0.011944:0.008734:0.010954:0.009134:0.005205:0.007808:0.008655:0.008990:0.004375:0.002858:0.008080:0.007297:0.008239:0.010954:0.008623:0.005637:0.006770:0.007377:0.009038:0.008080:0.013748:0.008351:0.006563:0.003465:0.005605:0.011848:0.009405:0.004040:0.007649:0.009405:0.006467:0.008830:0.007904:0.007473:0.008064:0.005637:0.009405:0.004040:0.004998:0.004998:0.008351:0.005557:0.008351:0.009038:0.005413:0.004375
approaches to the triaging of claims.  Excluding those schemes, the percentage of clinical claims that :@0.048407:0.620078:0.767179:0.620078:0.767179:0.609494:0.048407:0.609494:0.008128:0.009389:0.009213:0.005557:0.009357:0.008128:0.007377:0.008830:0.008351:0.006770:0.005221:0.005413:0.009134:0.004870:0.005413:0.009038:0.008080:0.005716:0.005205:0.005557:0.003689:0.008128:0.009102:0.003864:0.008830:0.009405:0.006307:0.009357:0.004758:0.005637:0.007138:0.003864:0.007728:0.003864:0.013365:0.006770:0.003225:0.004375:0.003273:0.008080:0.007042:0.007377:0.003625:0.008830:0.009165:0.003864:0.008655:0.009165:0.006052:0.005413:0.008782:0.009165:0.006770:0.008351:0.005892:0.006770:0.007377:0.009038:0.008080:0.013748:0.008096:0.006770:0.003465:0.006403:0.005413:0.009038:0.008160:0.006052:0.009165:0.008351:0.005349:0.007377:0.008175:0.009038:0.005413:0.007904:0.009405:0.008080:0.006052:0.009357:0.004758:0.005637:0.007377:0.003545:0.003864:0.008495:0.003864:0.006978:0.007808:0.003864:0.006307:0.007377:0.003864:0.007840:0.003864:0.013445:0.006770:0.004822:0.005413:0.009038:0.008319:0.005413:0.004375
have resolved without damages being  paid  has increased from 36%  (2020/21) to 41 %  (2021/22).:@0.048828:0.635518:0.746266:0.635518:0.746266:0.624934:0.048828:0.624934:0.008830:0.007904:0.007473:0.008064:0.006052:0.005205:0.007904:0.006467:0.008910:0.003864:0.007138:0.007984:0.008990:0.005637:0.012024:0.004040:0.005716:0.009405:0.009836:0.009405:0.005637:0.005301:0.009405:0.008128:0.013477:0.008128:0.009405:0.008351:0.006770:0.006084:0.008910:0.007904:0.003609:0.008575:0.008910:0.004375:0.002523:0.008830:0.007473:0.003609:0.008734:0.004375:0.002427:0.008734:0.007728:0.006563:0.005637:0.003864:0.008734:0.007138:0.005381:0.008160:0.007808:0.006770:0.007936:0.009165:0.006052:0.004790:0.005557:0.009150:0.013525:0.006052:0.009501:0.009581:0.014451:0.004375:0.002427:0.004822:0.009038:0.008607:0.008958:0.008607:0.006515:0.008607:0.008958:0.004822:0.005349:0.005413:0.009038:0.005301:0.007393:0.007473:0.004870:0.013700:0.004375:0.002938:0.004822:0.008878:0.008607:0.008782:0.008607:0.006227:0.008782:0.008607:0.005014:0.003465
Figure 9::@0.048828:0.678406:0.115237:0.678406:0.115237:0.667265:0.048828:0.667265:0.008404:0.004774:0.009850:0.009833:0.006387:0.008740:0.005631:0.008236:0.004555
Litigation rate for clinical claims (2017/18 to 2021/22):@0.049248:0.694916:0.460492:0.694916:0.460492:0.683775:0.049248:0.683775:0.008236:0.004370:0.005883:0.004370:0.010421:0.008908:0.006051:0.004370:0.010337:0.010001:0.006891:0.006135:0.008908:0.005967:0.009244:0.005631:0.005715:0.010589:0.006303:0.005631:0.008068:0.004068:0.004252:0.009749:0.004068:0.008118:0.008824:0.004068:0.006858:0.007765:0.004068:0.008757:0.004068:0.014472:0.007127:0.006185:0.005076:0.009060:0.008807:0.009060:0.008757:0.006555:0.008740:0.009060:0.004605:0.006085:0.010169:0.006471:0.008824:0.008824:0.008740:0.008824:0.006555:0.008656:0.008824:0.005076
2017/18:@0.081099:0.736643:0.131120:0.736643:0.131120:0.727730:0.081099:0.727730:0.007396:0.007315:0.007315:0.007315:0.005634:0.007315:0.007732
2018/19:@0.081519:0.771683:0.130761:0.771683:0.130761:0.762770:0.081519:0.762770:0.007140:0.007140:0.007234:0.007221:0.005553:0.007221:0.007732
2019/20:@0.081519:0.806485:0.131204:0.806485:0.131204:0.797572:0.081519:0.797572:0.007315:0.007315:0.007234:0.007234:0.005634:0.007221:0.007732
2020/21:@0.081856:0.841870:0.128460:0.841870:0.128460:0.834071:0.081856:0.834071:0.006765:0.006765:0.007142:0.006765:0.005424:0.006977:0.006765
2021/22:@0.081519:0.877034:0.130179:0.877034:0.130179:0.868678:0.081519:0.868678:0.007059:0.007249:0.007249:0.007022:0.005585:0.007249:0.007249
| |  :@0.224288:0.910649:0.241054:0.910649:0.241054:0.902292:0.224288:0.902292:0.004110:0.002534:0.004110:0.002534:0.003479
Proportion of claims settled without court proceedings:@0.253710:0.910649:0.598336:0.910649:0.598336:0.902292:0.253710:0.902292:0.007980:0.005206:0.007904:0.007980:0.007702:0.005320:0.004904:0.003832:0.007904:0.007816:0.004450:0.008484:0.005206:0.003479:0.006442:0.003782:0.007059:0.003782:0.012014:0.005799:0.004034:0.005799:0.007059:0.005131:0.004904:0.003920:0.007059:0.008068:0.004879:0.011005:0.003870:0.005458:0.008320:0.008484:0.008320:0.005383:0.004034:0.006215:0.007980:0.007816:0.005206:0.004904:0.004589:0.008068:0.005206:0.007904:0.006303:0.007148:0.007059:0.008156:0.003580:0.008017:0.008156:0.005547
 :@0.598588:0.910649:0.602042:0.910649:0.602042:0.902292:0.598588:0.902292:0.003454
|  Proportion of claims settled after court proceedings start:@0.236390:0.928768:0.611614:0.928768:0.611614:0.919855:0.236390:0.919855:0.001170:0.003711:0.012425:0.007987:0.005352:0.007759:0.007987:0.007893:0.005123:0.005231:0.003510:0.007893:0.007812:0.004451:0.008404:0.005150:0.003711:0.006266:0.003819:0.006858:0.003819:0.011900:0.005715:0.004451:0.005715:0.007275:0.004908:0.005042:0.003819:0.007100:0.008068:0.004881:0.007234:0.005150:0.005231:0.007275:0.005352:0.004464:0.006226:0.007987:0.007812:0.005352:0.004895:0.004451:0.008149:0.005352:0.007933:0.006454:0.006912:0.007275:0.007933:0.003819:0.007772:0.008068:0.005715:0.004451:0.005916:0.005231:0.007234:0.005150:0.005231
The number of claims with and without proceedings will differ from those  reported  in 2020/21 :@0.057316:0.953284:0.594973:0.953284:0.594973:0.945485:0.057316:0.945485:0.006636:0.007224:0.006636:0.004871:0.007059:0.007142:0.010930:0.007401:0.006636:0.004365:0.003694:0.007565:0.004118:0.004036:0.005800:0.003024:0.006389:0.003024:0.010754:0.005295:0.003612:0.009495:0.003189:0.004542:0.007401:0.004789:0.006306:0.006977:0.007306:0.004036:0.009495:0.003189:0.004542:0.007483:0.007730:0.007483:0.004459:0.004459:0.007306:0.004365:0.007306:0.005800:0.006471:0.006471:0.007401:0.002847:0.007236:0.007306:0.005212:0.003694:0.009330:0.003189:0.003189:0.003189:0.004871:0.007565:0.003106:0.004036:0.004036:0.006636:0.004459:0.003612:0.003871:0.004283:0.007306:0.010754:0.004459:0.004200:0.007224:0.007401:0.005295:0.006553:0.003224:0.001988:0.004094:0.006412:0.007142:0.007142:0.004283:0.003989:0.006601:0.007142:0.003224:0.001988:0.002847:0.006059:0.004871:0.006636:0.006636:0.006553:0.006636:0.004589:0.006754:0.006553:0.003224
as we  have  retrospectively incorporated  historical claims received  under our ELSGP.:@0.057652:0.965280:0.522867:0.965280:0.522867:0.957481:0.057652:0.957481:0.006224:0.004989:0.003753:0.009836:0.007142:0.003224:0.001988:0.006659:0.006201:0.005883:0.006153:0.003224:0.002141:0.004365:0.006471:0.003989:0.004494:0.007224:0.005212:0.007306:0.006471:0.005718:0.003989:0.003153:0.005883:0.006471:0.003024:0.006048:0.004459:0.003106:0.007059:0.005800:0.007306:0.004365:0.007306:0.007306:0.004365:0.006306:0.004200:0.006553:0.007306:0.003224:0.001988:0.006977:0.003024:0.005295:0.003989:0.007354:0.004283:0.003024:0.005636:0.006224:0.003024:0.004459:0.005800:0.003024:0.006389:0.003024:0.010754:0.005295:0.004871:0.004283:0.006153:0.005777:0.006153:0.003094:0.005636:0.006471:0.007142:0.003224:0.002071:0.007059:0.007142:0.007483:0.006553:0.004459:0.003612:0.007483:0.007306:0.004542:0.004459:0.005953:0.005542:0.006248:0.007895:0.006589:0.002553